论文部分内容阅读
目的探讨黛力新治疗心血管神经症患者焦虑抑郁情绪的临床疗效。方法将72例心血管神经症患者随机分为两组,研究组36例,应用黛力新加常规治疗;对照组36例,应用常规治疗。观察6w。于治疗前及治疗第6w末采用Zung氏焦虑自评量表(SAS)及抑郁自评量表(SDS)评定焦虑抑郁情绪,并进行对比分析。结果治疗6w末研究组SAS及SDS较治疗前显著下降(p<0.001),较对照组亦显著下降(p<0.001)。治疗6w末研究组显效率为88.89%,对照组为66.67%;研究组显著高于对照组(p<0.05)。结论黛力新能显著改善或缓解心血管神经症患者焦虑抑郁情绪,疗效显著优于常规治疗。
Objective To investigate the clinical efficacy of Deanxit in the treatment of anxiety and depression in patients with cardiovascular neurosis. Methods 72 patients with cardiovascular neurosis were randomly divided into two groups, study group 36 cases, dexamethasone plus routine treatment; control group 36 cases, the application of conventional therapy. Observe 6w. Before treatment and at the end of 6th week of treatment, anxiety and depression were assessed by SAS and SDS respectively. Results At the end of the 6th week, the SAS and SDS in the study group decreased significantly (p <0.001) compared with the control group, and also significantly decreased compared with the control group (p <0.001). At the end of the 6th week, the effective rate of the study group was 88.89%, while that of the control group was 66.67%. The study group was significantly higher than the control group (p <0.05). Conclusion Deanin can significantly improve or relieve anxiety and depression in patients with cardiovascular neurosis, the effect is significantly better than conventional treatment.